Diabetes and malaria: a dangerous link in cameroon?

NCT ID NCT06278181

Completed Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study in Cameroon followed 406 adults with and without type 2 diabetes for one year. Researchers tested blood and stool samples at four time points to see if diabetes increases the risk of malaria and other parasitic infections. The goal is to understand how non-communicable diseases like diabetes affect natural protection against parasites in regions where these infections are common.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand whether people with diabetes are more vulnerable to malaria and other parasites, leading to better prevention advice.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Burkitt lymphoma diabetes mellitus malaria metabolic syndrome X type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS ENDEMIC MALARIA METABOLIC SYNDROME

Contacts and locations

Locations

Limbe Regional Hospital

Limbe, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.